20 June 2013
Keywords: lilly, evista, available, japan, china, drug, major
Article | 24 May 2004
US drug major Eli Lilly and its Japanese marketing partner Chugai Pharmaceutical have launched Evista (raloxifene) in Japan for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.